188 related articles for article (PubMed ID: 33143618)
1. New Insights on Fak and Fak Inhibitors.
Brullo C; Tasso B
Curr Med Chem; 2021; 28(17):3318-3338. PubMed ID: 33143618
[TBL] [Abstract][Full Text] [Related]
2. The Development of FAK Inhibitors: A Five-Year Update.
Spallarossa A; Tasso B; Russo E; Villa C; Brullo C
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35742823
[TBL] [Abstract][Full Text] [Related]
3. Drug Discovery Targeting Focal Adhesion Kinase (FAK) as a Promising Cancer Therapy.
Pang XJ; Liu XJ; Liu Y; Liu WB; Li YR; Yu GX; Tian XY; Zhang YB; Song J; Jin CY; Zhang SY
Molecules; 2021 Jul; 26(14):. PubMed ID: 34299525
[TBL] [Abstract][Full Text] [Related]
4. Targeting focal adhesion kinase (FAK) for cancer therapy: FAK inhibitors, FAK-based dual-target inhibitors and PROTAC degraders.
Yang M; Xiang H; Luo G
Biochem Pharmacol; 2024 Jun; 224():116246. PubMed ID: 38685282
[TBL] [Abstract][Full Text] [Related]
5. Focal adhesion kinase inhibitors in the treatment of metastatic cancer: a patent review.
Shanthi E; Krishna MH; Arunesh GM; Venkateswara Reddy K; Sooriya Kumar J; Viswanadhan VN
Expert Opin Ther Pat; 2014 Oct; 24(10):1077-100. PubMed ID: 25113248
[TBL] [Abstract][Full Text] [Related]
6. Focal adhesion kinase-An emerging viable target in cancer and development of focal adhesion kinase inhibitors.
Chauhan A; Khan T
Chem Biol Drug Des; 2021 Mar; 97(3):774-794. PubMed ID: 33191630
[TBL] [Abstract][Full Text] [Related]
7. Focal adhesion kinase as a cancer therapy target.
Golubovskaya VM
Anticancer Agents Med Chem; 2010 Dec; 10(10):735-41. PubMed ID: 21214510
[TBL] [Abstract][Full Text] [Related]
8. FAK inhibitors in Cancer, a patent review.
Lv PC; Jiang AQ; Zhang WM; Zhu HL
Expert Opin Ther Pat; 2018 Feb; 28(2):139-145. PubMed ID: 29210300
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances of Small Molecule Focal Adhesion Kinase (FAK) Inhibitors as Promising Anticancer Therapeutics.
Lv P; Chen K; Zhu HL
Curr Med Chem; 2021 Oct; 28(34):6977-6989. PubMed ID: 33797359
[TBL] [Abstract][Full Text] [Related]
10. Prospects of focal adhesion kinase inhibitors as a cancer therapy in preclinical and early phase study.
Gao J; Cheng J; Xie W; Zhang P; Liu X; Wang Z; Zhang B
Expert Opin Investig Drugs; 2024 Jun; 33(6):639-651. PubMed ID: 38676368
[TBL] [Abstract][Full Text] [Related]
11. FAK signaling in human cancer as a target for therapeutics.
Lee BY; Timpson P; Horvath LG; Daly RJ
Pharmacol Ther; 2015 Feb; 146():132-49. PubMed ID: 25316657
[TBL] [Abstract][Full Text] [Related]
12. FAK-targeted and combination therapies for the treatment of cancer: an overview of phase I and II clinical trials.
Mohanty A; Pharaon RR; Nam A; Salgia S; Kulkarni P; Massarelli E
Expert Opin Investig Drugs; 2020 Apr; 29(4):399-409. PubMed ID: 32178538
[No Abstract] [Full Text] [Related]
13. The roles of nuclear focal adhesion kinase (FAK) on Cancer: a focused review.
Zhou J; Yi Q; Tang L
J Exp Clin Cancer Res; 2019 Jun; 38(1):250. PubMed ID: 31186061
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic potential and limitations of new FAK inhibitors in the treatment of cancer.
Schultze A; Fiedler W
Expert Opin Investig Drugs; 2010 Jun; 19(6):777-88. PubMed ID: 20465362
[TBL] [Abstract][Full Text] [Related]
15. Focal adhesion kinase: a potential target in cancer therapy.
van Nimwegen MJ; van de Water B
Biochem Pharmacol; 2007 Mar; 73(5):597-609. PubMed ID: 16997283
[TBL] [Abstract][Full Text] [Related]
16. Understanding the roles of FAK in cancer: inhibitors, genetic models, and new insights.
Yoon H; Dehart JP; Murphy JM; Lim ST
J Histochem Cytochem; 2015 Feb; 63(2):114-28. PubMed ID: 25380750
[TBL] [Abstract][Full Text] [Related]
17. Development of focal adhesion kinase inhibitors in cancer therapy.
Ma WW
Anticancer Agents Med Chem; 2011 Sep; 11(7):638-42. PubMed ID: 21787276
[TBL] [Abstract][Full Text] [Related]
18. Clinical importance and potential use of small molecule inhibitors of focal adhesion kinase.
Schultze A; Fiedler W
Anticancer Agents Med Chem; 2011 Sep; 11(7):593-9. PubMed ID: 21787277
[TBL] [Abstract][Full Text] [Related]
19. Focal adhesion kinase inhibitors in the treatment of solid tumors: Preclinical and clinical evidence.
Quispe PA; Lavecchia MJ; León IE
Drug Discov Today; 2022 Feb; 27(2):664-674. PubMed ID: 34856395
[TBL] [Abstract][Full Text] [Related]
20. Progress in the Development of Small Molecular Inhibitors of Focal Adhesion Kinase (FAK).
Lu Y; Sun H
J Med Chem; 2020 Dec; 63(23):14382-14403. PubMed ID: 33058670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
